Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.

Spain's Naturgy plans to buy back almost 2.5-billion euros ($2.6 billion) of its shares, up to 10% of its capital, then ...

Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.

Bruker Corporation today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

As HR's strategic role evolves, people professionals must leverage tech alongside human skills to drive success, says BVI ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 development for immunology, inflammation, and neurology disorders, today ...

The S&P 500 ended 2024 with a 25% gain for the year. This marks the second consecutive year of gains exceeding 25% and the third such occurrence in the past four years.

A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...